17th May 2013 09:51
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | GlaxoSmithKline Share Option Plan - Ordinary Shares  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 9,717,201  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 10,000,000  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 11,294,858  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 8,422,343  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | GlaxoSmithKline Share Option Plan - ADS  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 8,362,078  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 15,000,000  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 14,701,554  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 8,660,524  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | Glaxo Wellcome UK Share Option Scheme  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 5,119,750  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 0  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 5,119,750  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | Glaxo Wellcome International Share Option Scheme  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 13,267,156  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 0  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 13,267,156  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | Glaxo Wellcome 1999 Share Option Plan  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 1,040,000  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 0  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 1,040,000  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 163,606  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 0  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 163,606  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 275,420  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 0  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 275,420  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 100,000  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 0  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 100,000  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | GlaxoSmithKline Savings Related Share Option Scheme  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 3,889,981  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 0  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 1,077,551  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 2,812,430  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 17 May 2013
Name of applicant:  | GlaxoSmithKline plc  | |||
Name of scheme:  | GlaxoSmithKline plc Sharesave plan 2012  | |||
Period of return:  | From:  | 1 November 2012  | To:  | 13 May 2013  | 
Balance of unallotted securities under scheme(s) from previous return:  | 0  | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):  | 5,000  | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):  | 4  | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period:  | 4,996  | |||
Name of contact:  | Victoria Whyte  | 
Telephone number of contact:  | 020 8047 5000  | 
Related Shares:
Glaxosmithkline